When Does Ultragenyx Pharmaceutical Report Earnings?

RARE · Nasdaq · Next expected earnings date for Ultragenyx Pharmaceutical Inc., from its SEC filing history, with a live countdown in trading days.

Ultragenyx Pharmaceutical Inc.RARE

Next earnings date

Thursday, Feb 11, 2027

After the close

Fiscal Q4 2026 · quarter ended December 31, 2026

54trading days
83calendar days
Expected

Typically accurate to within 3 days

After that

Fiscal Q1 2027

Expected May 4, 2027 · after the close

Last reported

Fiscal Q3 2026

Oct 30, 2026 · time not yet known · 8-K

Fiscal year

Jan 1 – Dec 31

Fiscal year 2026 ends Dec 31, 2026

RARE earnings date history

The last 8 earnings releases, from Ultragenyx Pharmaceutical's SEC filings, its earnings 8-Ks, or the quarterly report itself when results are published that way. The “days after” column is how long after the fiscal quarter ended the company reported, the pattern behind the expected date above.

QuarterReportedTimeDays after
Q3 2026ended Sep 30Oct 30, 2026Friday-30
Q2 2026ended Jun 30Aug 4, 2026TuesdayAfter close35
Q1 2026ended Mar 31May 5, 2026TuesdayAfter close35
Q4 2025ended Dec 31Feb 12, 2026ThursdayAfter close43
Q3 2025ended Sep 30Nov 3, 2025MondayAfter close34
Q2 2025ended Jun 30Aug 5, 2025TuesdayAfter close36
Q1 2025ended Mar 31May 6, 2025TuesdayAfter close36
Q4 2024ended Dec 31Feb 13, 2025ThursdayAfter close44

How this expected date is worked out

Companies report on a rhythm. We read every Form 8-K earnings release and 10-Q/10-K Ultragenyx Pharmaceutical has filed with the SEC, work out how many days after each fiscal quarter ended the results came out and on which weekday, and project that pattern onto the current quarter, using the same fiscal quarter from prior years, since fourth-quarter reports run later than the others. The result is snapped to a trading day and capped at the SEC filing deadline for a large accelerated filer.

Whether a company reports before the open or after the close comes from the time its past earnings 8-Ks reached the SEC. When Ultragenyx Pharmaceutical announces an exact date, this page switches from expected to confirmed. Until then, verify the date with the company's investor relations site before trading around it.

More earnings dates

Looking for another company? Browse all companies by name, sector or report date.

Frequently asked questions

When does Ultragenyx Pharmaceutical (RARE) report earnings?›

Ultragenyx Pharmaceutical is expected to report Fiscal Q4 2026 earnings on Thursday, February 11, 2027, after the market closes.

How many trading days until RARE earnings?›

54 trading days (83 calendar days) as of Friday, November 20, 2026, counting weekdays and skipping NYSE/Nasdaq holidays.

Does RARE report before or after the market opens?›

Ultragenyx Pharmaceutical typically reports after the market closes, based on when its past earnings 8-K filings reached the SEC.

Expected dates are projections from public SEC filings, not announcements by Ultragenyx Pharmaceutical Inc. Confirm with the company before making decisions. Not investment advice. See the Terms of Service.